Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Awake craniotomy versus piloting an aircraft: What medicine and aviation can learn from one another?

Khurana VG, Vats P.

Surg Neurol Int. 2019 Jun 7;10:93. doi: 10.25259/SNI-215-2019. eCollection 2019. No abstract available.

2.

Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers.

Carmona-Abellan M, Gabilondo I, Murueta-Goyena A, Khurana V, Tijero B, Luquin MR, Acera M, Del Pino R, Gardeazabal J, Martínez-Valbuena I, Sanchez-Pernaute R, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2019 Aug;65:139-145. doi: 10.1016/j.parkreldis.2019.05.038. Epub 2019 Jun 5.

PMID:
31178336
3.

Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells.

Lam I, Hallacli E, Khurana V.

Cold Spring Harb Perspect Biol. 2020 Feb 3;12(2). pii: a034124. doi: 10.1101/cshperspect.a034124. Review.

PMID:
30910772
4.

In Situ Peroxidase Labeling and Mass Spectrometry of Alpha-Synuclein in Rat Cortical Neurons.

Sanz R, Ovando-Roche P, Udeshi ND, Carr SA, Chung CY, Khurana V.

Methods Mol Biol. 2019;1948:235-246. doi: 10.1007/978-1-4939-9124-2_18.

PMID:
30771182
5.

The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis.

Freedman MS, Duquette P, Grand'Maison F, Lee L, Vorobeychik G, Lara N, Khurana V, Nakhaipour HR, Schecter R, Haddad P.

Curr Med Res Opin. 2019 May;35(5):767-776. doi: 10.1080/03007995.2019.1565818. Epub 2019 Jan 21.

PMID:
30614288
6.

Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity.

Vincent BM, Tardiff DF, Piotrowski JS, Aron R, Lucas MC, Chung CY, Bacherman H, Chen Y, Pires M, Subramaniam R, Doshi DB, Sadlish H, Raja WK, Solís EJ, Khurana V, Le Bourdonnec B, Scannevin RH, Rhodes KJ.

Cell Rep. 2018 Dec 4;25(10):2742-2754.e31. doi: 10.1016/j.celrep.2018.11.028.

7.

A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.

Khurana VK, Misri RR, Agarwal S, Thole AV, Kumar S, Anand T.

Indian J Dermatol Venereol Leprol. 2019 Jan-Feb;85(1):39-43. doi: 10.4103/ijdvl.IJDVL_801_16.

8.

Cardiogenic Dysphagia: Dysphagia Megalatriensis.

Khurana V, Thakur SK.

Am J Med Sci. 2018 Mar;355(3):e9. doi: 10.1016/j.amjms.2017.10.002. Epub 2017 Oct 12. No abstract available.

PMID:
29549936
9.

Eruptive Vellus Hair Cyst: An Uncommon and Underdiagnosed Entity.

Anand P, Sarin N, Misri R, Khurana VK.

Int J Trichology. 2018 Jan-Feb;10(1):31-33. doi: 10.4103/ijt.ijt_61_17.

10.

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J.

Neurology. 2018 Jan 9;90(2):74-82. doi: 10.1212/WNL.0000000000004798. Epub 2017 Dec 13.

11.

Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations.

Jarosz DF, Khurana V.

Cell. 2017 Nov 16;171(5):1001-1014. doi: 10.1016/j.cell.2017.10.047. Review.

12.

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.

Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schüle B, Park DS, Riise T, Scherzer CR.

Science. 2017 Sep 1;357(6354):891-898. doi: 10.1126/science.aaf3934.

13.

Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures.

Khurana V, Sharma H, Afroz N, Callan A, Medin J.

Eur J Neurol. 2017 Sep;24(9):1099-1107. doi: 10.1111/ene.13339. Epub 2017 Jul 11. Review.

PMID:
28695634
14.

Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery.

Mandal A, Cholkar K, Khurana V, Shah A, Agrahari V, Bisht R, Pal D, Mitra AK.

Mol Pharm. 2017 Jun 5;14(6):2056-2069. doi: 10.1021/acs.molpharmaceut.7b00128. Epub 2017 May 17.

PMID:
28471177
15.

From Yeast to Patients: The Audacity and Vision of Susan Lindquist.

Khurana V, Chung CY, Tardiff DF.

Cell Syst. 2017 Feb 22;4(2):147-148. doi: 10.1016/j.cels.2017.02.007. No abstract available.

16.

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S.

Clin Pharmacol. 2017 Jan 11;9:9-17. doi: 10.2147/CPAA.S119676. eCollection 2017.

17.

In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons.

Chung CY, Khurana V, Yi S, Sahni N, Loh KH, Auluck PK, Baru V, Udeshi ND, Freyzon Y, Carr SA, Hill DE, Vidal M, Ting AY, Lindquist S.

Cell Syst. 2017 Feb 22;4(2):242-250.e4. doi: 10.1016/j.cels.2017.01.002. Epub 2017 Jan 25.

18.

Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways.

Khurana V, Peng J, Chung CY, Auluck PK, Fanning S, Tardiff DF, Bartels T, Koeva M, Eichhorn SW, Benyamini H, Lou Y, Nutter-Upham A, Baru V, Freyzon Y, Tuncbag N, Costanzo M, San Luis BJ, Schöndorf DC, Barrasa MI, Ehsani S, Sanjana N, Zhong Q, Gasser T, Bartel DP, Vidal M, Deleidi M, Boone C, Fraenkel E, Berger B, Lindquist S.

Cell Syst. 2017 Feb 22;4(2):157-170.e14. doi: 10.1016/j.cels.2016.12.011. Epub 2017 Jan 25.

19.

Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Parikh N, Kramer WG, Khurana V, Cognata Smith C, Vetticaden S.

Clin Pharmacol. 2016 Oct 12;8:155-162. eCollection 2016.

20.

Idiopathic Eruptive Macular Pigmentation with Papillomatosis: An Unfamiliar Entity.

Misri RR, Khurana VK, Thole AV, Nagad MB.

Indian J Dermatol. 2016 Sep-Oct;61(5):581. doi: 10.4103/0019-5154.190135. No abstract available.

21.

Transporter effects on cell permeability in drug delivery.

Mandal A, Agrahari V, Khurana V, Pal D, Mitra AK.

Expert Opin Drug Deliv. 2017 Mar;14(3):385-401. doi: 10.1080/17425247.2016.1214565. Epub 2016 Aug 5. Review.

PMID:
27449574
22.

Novel delivery approaches for cancer therapeutics.

Mitra AK, Agrahari V, Mandal A, Cholkar K, Natarajan C, Shah S, Joseph M, Trinh HM, Vaishya R, Yang X, Hao Y, Khurana V, Pal D.

J Control Release. 2015 Dec 10;219:248-268. doi: 10.1016/j.jconrel.2015.09.067. Epub 2015 Oct 9. Review.

23.

Toward stem cell-based phenotypic screens for neurodegenerative diseases.

Khurana V, Tardiff DF, Chung CY, Lindquist S.

Nat Rev Neurol. 2015 Jun;11(6):339-50. doi: 10.1038/nrneurol.2015.79. Epub 2015 May 19. Review.

PMID:
25986505
24.

Widespread macromolecular interaction perturbations in human genetic disorders.

Sahni N, Yi S, Taipale M, Fuxman Bass JI, Coulombe-Huntington J, Yang F, Peng J, Weile J, Karras GI, Wang Y, Kovács IA, Kamburov A, Krykbaeva I, Lam MH, Tucker G, Khurana V, Sharma A, Liu YY, Yachie N, Zhong Q, Shen Y, Palagi A, San-Miguel A, Fan C, Balcha D, Dricot A, Jordan DM, Walsh JM, Shah AA, Yang X, Stoyanova AK, Leighton A, Calderwood MA, Jacob Y, Cusick ME, Salehi-Ashtiani K, Whitesell LJ, Sunyaev S, Berger B, Barabási AL, Charloteaux B, Hill DE, Hao T, Roth FP, Xia Y, Walhout AJM, Lindquist S, Vidal M.

Cell. 2015 Apr 23;161(3):647-660. doi: 10.1016/j.cell.2015.04.013.

25.

Answer: An uncommon organism in ascitic fluid.

Khurana V, Dasgupta J, Basu K, Ray S.

Ann Saudi Med. 2014 Jul-Aug;34(4):358a. doi: 10.5144/0256-4947.2014.358a. No abstract available.

26.

An uncommon organism in ascitic fluid.

Khurana V, Dasgupta J, Basu K, Ray S.

Ann Saudi Med. 2014 Jul-Aug;34(4):358-8a. doi: 10.5144/0256-4947.2014.358. No abstract available.

27.

A clinico-epidemiological study of cognitive function status of community-dwelling elderly.

Gambhir IS, Khurana V, Kishore D, Sinha AK, Mohapatra SC.

Indian J Psychiatry. 2014 Oct;56(4):365-70. doi: 10.4103/0019-5545.146531.

28.

Recurrent acute pancreatitis.

Khurana V, Ganguly I.

JOP. 2014 Sep 28;15(5):413-26. doi: 10.6092/1590-8577/2417.

29.

Long-term delivery of protein therapeutics.

Vaishya R, Khurana V, Patel S, Mitra AK.

Expert Opin Drug Deliv. 2015 Mar;12(3):415-40. doi: 10.1517/17425247.2015.961420. Epub 2014 Sep 24. Review.

30.

From yeast to patient neurons and back again: powerful new discovery platform.

Tardiff DF, Khurana V, Chung CY, Lindquist S.

Mov Disord. 2014 Sep;29(10):1231-40. doi: 10.1002/mds.25989. Epub 2014 Aug 14.

PMID:
25131316
31.

Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.

Khurana V, Kwatra D, Pal D, Mitra AK.

Int J Pharm. 2014 Oct 20;474(1-2):14-24. doi: 10.1016/j.ijpharm.2014.07.056. Epub 2014 Aug 4.

32.

Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells.

Khurana V, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK.

Curr Eye Res. 2015 May;40(5):457-69. doi: 10.3109/02713683.2014.935443. Epub 2014 Jul 11.

33.

Controlled ocular drug delivery with nanomicelles.

Vaishya RD, Khurana V, Patel S, Mitra AK.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Sep-Oct;6(5):422-37. doi: 10.1002/wnan.1272. Epub 2014 Jun 2. Review.

34.

Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors.

Khurana V, Minocha M, Pal D, Mitra AK.

Drug Metabol Drug Interact. 2014;29(4):249-59. doi: 10.1515/dmdi-2014-0014.

35.

Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors.

Khurana V, Minocha M, Pal D, Mitra AK.

Drug Metabol Drug Interact. 2014;29(3):179-90. doi: 10.1515/dmdi-2013-0062.

36.

Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.

Kwatra D, Vadlapudi AD, Vadlapatla RK, Khurana V, Pal D, Mitra AK.

Drug Metabol Drug Interact. 2014;29(2):101-10. doi: 10.1515/dmdi-2013-0056.

37.

Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons.

Tardiff DF, Jui NT, Khurana V, Tambe MA, Thompson ML, Chung CY, Kamadurai HB, Kim HT, Lancaster AK, Caldwell KA, Caldwell GA, Rochet JC, Buchwald SL, Lindquist S.

Science. 2013 Nov 22;342(6161):979-83. doi: 10.1126/science.1245321. Epub 2013 Oct 24.

38.

Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.

Chung CY, Khurana V, Auluck PK, Tardiff DF, Mazzulli JR, Soldner F, Baru V, Lou Y, Freyzon Y, Cho S, Mungenast AE, Muffat J, Mitalipova M, Pluth MD, Jui NT, Schüle B, Lippard SJ, Tsai LH, Krainc D, Buchwald SL, Jaenisch R, Lindquist S.

Science. 2013 Nov 22;342(6161):983-7. doi: 10.1126/science.1245296. Epub 2013 Oct 24.

39.

A case of syringocystadenoma papilliferum on lower leg: a rare location.

Khurana VK, Mehta RK, Chaudhary D, Pant L.

Indian J Dermatol. 2013 Sep;58(5):405. doi: 10.4103/0019-5154.117306.

40.

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study.

Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR.

Neurology. 2013 Oct 22;81(17):1531-7. doi: 10.1212/WNL.0b013e3182a95818. Epub 2013 Sep 25.

41.

Clinico-mycological evaluation of dermatophytes and non-dermatophytes isolated from various clinical samples: A study from north India.

Sharma Y, Jain S, Chandra K, Khurana VK, Kudesia M.

J Res Med Sci. 2012 Aug;17(8):817-8. No abstract available.

42.

Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas.

Rao PJ, Jyoti R, Mews PJ, Desmond P, Khurana VG.

Br J Neurosurg. 2013 Oct;27(5):646-53. doi: 10.3109/02688697.2013.771724. Epub 2013 Mar 5.

PMID:
23461752
43.

A comparative study of closed versus open reduction and internal fixation (using retromandibular approach) in the management of subcondylar fracture.

Kotrashetti SM, Lingaraj JB, Khurana V.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Apr;115(4):e7-11. doi: 10.1016/j.oooo.2011.10.027. Epub 2012 Nov 10.

PMID:
23146571
44.

Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme.

Gaudana R, Gokulgandhi M, Khurana V, Kwatra D, Mitra AK.

Pharm Dev Technol. 2013 May-Jun;18(3):752-9. doi: 10.3109/10837450.2012.737806. Epub 2012 Nov 9.

45.

Congenital miliaria crystallina - A diagnostic dilemma.

Dixit S, Jain A, Datar S, Khurana VK.

Med J Armed Forces India. 2012 Oct;68(4):386-8. doi: 10.1016/j.mjafi.2012.01.004. Epub 2012 Jul 17.

46.

Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).

Minocha M, Khurana V, Mitra AK.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jul 15;901:85-92. doi: 10.1016/j.jchromb.2012.06.004. Epub 2012 Jun 15.

47.

Witkop syndrome: A case report of an affected family.

Khurana VK, Gupta RK, Kumar LP.

Dermatol Online J. 2012 Jun 15;18(6):2.

48.

Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib.

Minocha M, Khurana V, Qin B, Pal D, Mitra AK.

Int J Pharm. 2012 Oct 15;436(1-2):127-34. doi: 10.1016/j.ijpharm.2012.05.038. Epub 2012 Jun 9.

49.

Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.

Minocha M, Khurana V, Qin B, Pal D, Mitra AK.

Int J Pharm. 2012 Sep 15;434(1-2):306-14. doi: 10.1016/j.ijpharm.2012.05.028. Epub 2012 May 23.

50.

Intracranial haemorrhage with a twist.

Khurana VG, Spinner RJ, Wijdicks EF, Scheithauer BW.

J Clin Neurosci. 2012 Apr;19(4):561, 631. No abstract available.

PMID:
22482128

Supplemental Content

Loading ...
Support Center